The Use of Data Flashcards

1
Q

Definition of Disease

A

Symptoms, signs - diagnosis: a bio-medical perspective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Definition of Illness

A

Ideas, concerns, expectations - experience: patients perspective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What factors affect the uptake of care (4)

A

Concept of Lay referral - i.e. granny knows best

Sources of info - peers, family, internet, TV, newspaper

Medical - new symptoms, visible symptoms, increasing severity, duration

Non-medical - crisis, peer pressure (wife sent me), patient beliefs, expectations, social class, economic, psychological, environmental, cultural, ethnic, age, gender, media

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Possible issues from the patient about care (2)

Possible issues from the GP about care (2)

A

Believes to be healthy because is physically fit.
Proud not to be using tablets

Wish to perform a couple more tests – a Holter Monitor and an Echocardiogram – why might you do these tests?

Worried about the consequences for long term health.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 3 main epidemiological aims of being able to provide information to patients (3)

A

Description - to describe the amount and distribution of disease in human populations.

Explanation - to elucidate the natural history and identify aetiological factors for disease usually by combining epidemiological data with data from other disciplines such as biochemistry, occupational health and genetics.

Disease control - to provide the basis on which preventive measures, public health practices and therapeutic strategies can be developed, implemented, monitored and evaluated for the purposes of disease control.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does epidemiology compare? (1 + 3)

A

Groups (study populations) in order to detect differences pointing to –

  • Aetiological clues (what causes the problem)
  • The scope for prevention
  • The identification of high risk or priority groups in society.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which fundamental measures does epidemiology use to study disease and risk?

A

Talk in terms of ratio: Numerator / Denominator -

  • Event / Population at Risk
  • i.e. Deaths from IHD in men aged 55-64 in Grampian in 1990 / All men aged 55-64 in Grampian in 1990
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does the risk part in the ratios of studies of diseases mean

A

That everyone in the denominator has the potential to move into the numerator and in turn that everyone in the numerator has come from the denominator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is incidence

A

The number of new cases of a disease in a population in a specified period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is prevalence

A

The number of people within a population with a specific disease at a single point in time or in a defined period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What may have a high incidence but a low prevalence

What may have a low incidence but a high prevalence

A

High I - Low P = Minor illnesses - i.e. cold

Low I - High P = Chronic illnesses - i.e. diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is relative risk and how is it calculated

A

The measure of the strength of an association between a suspected risk factor and the disease under study

RR = incidence of disease in an exposed group / incidence of disease in an unexposed group

(see word document for example)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

10 sources of epidemiological data

A
Mortality data
Expenditure data from NHS
General practice morbidity
Hospital activity statistics
Reproductive health statistics
Cancer statistics
Accident statistics
Social security statistics
Health and household surveys
Drug misuse databases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is health literacy

A

About people having the knowledge, skills, understanding and confidence to use health information, to be active partners in their care, and to navigate health and social care systems.

Health literacy is being increasingly recognised as a significant health concern around the world

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the different types of studies (1,2(3), 3)

A
Descriptive 
Analytical 
- Cross-sectional 
- Case-Control 
- Cohort
Trials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a descriptive study

A

Attempt to describe the amount and distribution of a disease in a given population.

  • Follow the time, place, person framework
  • May look at disease alone or also look into factors (exposures) thought to be linked to the aetiology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When are descriptive epidemiological studies useful (5)

A
  1. Identifying emerging public health problems by monitoring and surveilling disease patterns
  2. Signalling effects worth of further investigation
  3. Assessing the effectiveness of measures of prevention and control (eg, screening programmes).
  4. Assessing needs for health services and service planning.
  5. Generating hypotheses about disease aetiology and risk factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What 3 things does a descriptive study not provide (3)

A
  1. Definitive conclusions about disease causation
  2. Evidence about the causes of disease
  3. Do not test hypotheses.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a benefit of descriptive studies (3)

A
  1. Cheap
  2. Quick
  3. Give a valuable initial overview of a problem
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What do cross-sectional studies look at and what do they conclude

A

Observations made at a single point in time - disease frequency, survey, prevalence study

Conclusions indicate relationship between diseases and other variables of interest in a defined population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is a pro and con to cross-sectional studies

A

Provide quick results

Is usually impossible to infer causation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does a case-control study compare

A

Two groups of people are compared:

  1. Group of individuals with the disease of interest are identified (cases)
  2. Group of individuals who do not have the disease (controls)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How is data gathered in a case-control study (3 steps)

A
  1. Data is gathered on each individual to determine whether or not they have been exposed to the suspected aetiological factor(s)
  2. The average exposure in the two groups, cases and controls is compared
  3. This identifies significant differences, give clues to factors which elevate (or reduce) risk of the disease under investigation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How are the results of a case-control study expressed (3)

A
  1. ‘odds ratios’
  2. ‘relative risks’ - also used for cohort & randomised trials
  3. Confidence intervals / ‘p values’ may be presented to guide whether the result could be a chance finding
25
Q

Steps of a cohort study (4)

A
  1. Baseline data on exposure is collected from a group of people who do not have the disease under study
  2. The group is then followed through time until a sufficient number have developed the disease to allow analysis.
  3. The original group is separated into subgroups according to original exposure status.
  4. These subgroups are compared to determine the incidence of disease according to exposure.
26
Q

What do cohort studies allow for (2)

A
  1. The calculation of cumulative incidence

2. For differences in follow up time

27
Q

What is a trial

A

Experiments used to test ideas about aetiology or to evaluate interventions.

28
Q

What is the definitive method of assessing any new treatment in medicine

A

Randomised control trial

29
Q

How does a randomised control trial work (4)

A
  1. Two groups at risk of developing a disease are assembled: a study (intervention) group and a control group.
  2. An alteration is made to the intervention group (eg, a suspected causative factor is removed or neutralised), whilst no alteration is made to the control group.
  3. Data on subsequent outcomes (eg, disease incidence) are collected in the same way from both groups
  4. The relative risk is calculated.
30
Q

What is the aim of randomised control trial

A

To determine whether modification of the factor (removing, reducing or increasing exposure) alters the incidence of the disease.

31
Q

How is a randomised control trial of new treatment used

A

The underlying design is the same:

  • the intervention group receive the new therapy
  • the control group receive the current standard therapy (or a placebo)
  • the treatment outcomes (eg, reduction in symptoms) are compared in the two groups.
32
Q

What 6 factors need to be considered when interpreting the results of a study

A
  1. Standardisation
  2. Standardised Mortality Ratio
  3. Quality of Data
  4. Case Definition
  5. Coding and Classification
  6. Ascertainment
33
Q

What is standardisation and give an example

A
  1. A set of techniques used to remove or adjust for the effects of differences when comparing two or more populations, in age, social class etc.

Age-sex standardised rate: represents what the unstandardised (crude) rate would have been in the study population, if that population had the same proportion of males and females, and of people in different age groups, as the standard population

34
Q

What is standardised mortality ratio (2) and give an example

A
  1. A standardised death rate converted into a ratio for easy comparison.
  2. The figure for a standard reference population (eg, Scotland) is taken to be 100 and the standardised death rates for the comparison (study) populations (eg, Grampian) are expressed as a proportion of 100.
    - A figure below one hundred means fewer than expected deaths, and above 100 means more.

i.e. an SMR of 120 means that 20% more deaths occurred than expected in the study population, allowing for differences in the age and sex structure of the standard and study populations and an SMR of 83 means 17% fewer deaths occurred

35
Q

What is quality of data

A

Ensuring that the data are trustworthy

36
Q

What is case definition

A

The purpose of case definition is to decide whether an individual has the condition of interest or not

Important as not all investigators mean the same thing when they use medical terms.

37
Q

What is coding and classification, what does it assist in

A
  1. When data is collected routinely, eg, death certificates, it is normal to convert disease information to a set of codes
  2. Assists in data storage and analysis
  3. Rules are drawn up to dictate how clinical information is converted to a code

(Related to the case definition)

If these rules change, it sometimes appears that a disease has become more or less common, when in fact it has just been coded under a new heading.

38
Q

What is ascertainment and how may it effect incidence

A

Is the data complete - are any subjects missing?

If researchers in one country look harder for cases of a given disease than researchers in any other, it might not be surprising that they come up with higher incidence rates.

39
Q

What is bias

A

Any trend in the collection, analysis, interpretation, publication or review of data that can lead to conclusions that are systematically different from the truth.

40
Q

What are the four different types of bias

A
  1. Selection Bias
  2. Information Bias
  3. Follow up Bias
  4. Systematic Error
41
Q

What is selection bias

A

Occurs when the study sample is not truly representative of the whole study population about which conclusions are to be drawn.

i.e. In a randomised controlled trial of a new drug, subjects should be allocated to the intervention (study) group and control group using a random method.

If certain types of people (eg, older, more ill) were deliberately allocated to one of these groups then the results of the trial would reflect these differences, not just the effect of the drug.

42
Q

What is information bias

A

Bias resulting from measurement error.

i.e. In a case control study, a researcher who was aware of whether the patient being interviewed was a ‘case’ or a ‘control’ might encourage cases more than controls to think hard about past exposures to the factors of interest.

Any differences in exposure would then reflect the enthusiasm of the researcher as well as any true difference in exposure between the two groups.

43
Q

What is follow-up bias

A

Arises when one group of subjects is followed up more assiduously than another to measure disease incidence or other relevant outcome.

i.e. In cohort studies, subjects sometimes move address or fail to reply to questionnaires sent out by the researchers.

If greater attempts are made to trace these missing subjects from the group with greater initial exposure to a factor of interest than from the group with less exposure, the resulting relative risk would be based on a (relative) underestimate of the incidence in the less exposed group compared with the more exposed group.

44
Q

What is systematic error bias

A

A form of measurement bias where your results are always either too high or too low

i.e. It may be because the instrument (eg, a blood pressure machine) is calibrated wrongly, or because of the way a person uses an instrument.

This problem may occur with interviews, questionnaires etc, as well as with medical instruments.

45
Q

What is a confounding factor

A

One which is associated independently with both the disease and with the exposure under investigation and so distorts the relationship between the exposure and disease.

In some cases, the confounding factor may be the true causal factor, and not the exposure that is under consideration.

46
Q

What are common confounders (3)

A

Age
Sex
Social class

47
Q

What are 5 ways to deal with confounding

A
  1. Randomisation in trials
  2. Restriction of eligibility criteria to only certain kinds of study subjects .
  3. Subjects in different groups can be matched for likely confounding factors.
  4. Results can be stratified according to confounding factors.
  5. Results can be adjusted (using multivariate analysis techniques) to take account of suspected confounding factors.
48
Q

Why is their a criteria for causality

A

It is difficult to prove causation between an exposure and disease and the criteria help to assess the available evidence

49
Q

What are the 9 criteria for causality

A
  1. Strength of association
  2. Consistency
  3. Specificity
  4. Temporality
  5. Biological gradient
  6. Biological plausibility
  7. Coherence
  8. Analogy
  9. Experiment
50
Q

What is strength of association

A

As measured by relative risk or odds ratio.

51
Q

What is consistency

A

Repeated observation of an association in different populations under different circumstances.

52
Q

What is specificity

A

A single exposure leading to a single disease.

53
Q

What is temporality

A

The exposure comes before the disease.

54
Q

What is biological gradient

A

Dose-response relationship. As the exposure increases so does the risk of disease.

55
Q

What is biological plausibility

A

The association agrees with what is known about the biology of the disease.

56
Q

What is coherence

A

The association does not conflict with what is known about the biology of the disease.

57
Q

What is analogy

A

Another exposure-disease relationship exists which can act as a model for the one under investigation.

i. e. it is known that certain drugs can cross the placenta and cause birth defects
- it might be possible for viruses to do the same.

58
Q

What is experiment

A

A suitably controlled experiment to prove the association as causal - very uncommon in human populations.

59
Q

Three intended aims of SIGN Guidelines

A
  1. Help patients. health and social care professional understand medical evidence and use it to make decisions about healthcare
  2. Reduce unwarranted variations in practice and make sure patients get the best care available, no matter where they live
  3. Improve healthcare across Scotland by focussing on patient-important outcomes